Ainnocence

Ainnocence is a next-generation biotech company founded in 2021 in California, specializing in generative AI for therapeutic discovery. Their innovative platform minimizes drug discovery risks and costs by up to 80%, enabling rapid virtual screening and pharmacological optimization for various therapeutic modalities. With the capability to screen billions of protein sequences and chemical compounds in hours, Ainnocence significantly accelerates the discovery of life-saving therapies while achieving high success rates. The company aims to reshape the future of R&D in healthcare through transformative advancements powered by AI.

AIBiotechComputational BiologyDrug DiscoveryInnovationMachine LearningPharmaceuticalsTherapeuticsainnocence.com

Ainnocence

AIBiotechComputational BiologyDrug DiscoveryInnovationMachine LearningPharmaceuticalsTherapeuticsainnocence.com

HQMountain View, US

Team Size8

Open Jobs2

Total Funding-

Latest Fundraise4 years ago

TL;DR

Founded: 2021

Headquarters: Bay Area / Mountain View, California

Focus: Sequence-first generative AI for therapeutic discovery and synthetic biology

Claims: Virtual screening up to 10 billion candidates; reported wet-lab hit rates 10–60%; 60+ validated deliveries

Company Overview

Problem Domain

Drug discovery and synthetic biology — reducing R&D time, cost, and failure risk through AI-enabled design and screening.

Founded

2021

Industry

Biotechnology

Tech Stack

Generative AI (proprietary platforms)

High-throughput virtual screening

Funding Track Record

Seed- 2021-11

Dealroom lists a November 2021 seed entry that names Genesis Capital and Iaso Ventures.

Seed- 2021-09-30

Company profile lists a last funding date of 2021-09-30 and indicates multiple funding rounds (Crunchbase records two rounds).

Investor Signal

“Investors named in public profiles include Genesis Capital and Iaso Ventures”

Founders

What we do

TL;DR

Company Overview

Funding Track Record

Founders

What we do

Ainnocence

AIBiotechComputational BiologyDrug DiscoveryInnovationMachine LearningPharmaceuticalsTherapeuticsainnocence.com

Ainnocence

AIBiotechComputational BiologyDrug DiscoveryInnovationMachine LearningPharmaceuticalsTherapeuticsainnocence.com

HQMountain View, US

Team Size8

Open Jobs2

Total Funding-

Latest Fundraise4 years ago

TL;DR

Founded: 2021

Headquarters: Bay Area / Mountain View, California

Focus: Sequence-first generative AI for therapeutic discovery and synthetic biology

Claims: Virtual screening up to 10 billion candidates; reported wet-lab hit rates 10–60%; 60+ validated deliveries

Related Companies

Company	HQ	Industry	Total Funding
GATC Health	🇺🇸Irvine, US	BiotechnologyDeepTech	$31M
NeuroDiscovery AI	🇺🇸Alpharetta, US	BiotechnologyDeepTechHealth	-
iollo	🇺🇸US	HealthSports	-
Prima Mente	🇬🇧London, GB	BiotechnologyDeepTech	-
Life Code Limited	🌍Hong Kong	BiotechnologyDeepTech	-

Company Overview

Problem Domain

Drug discovery and synthetic biology — reducing R&D time, cost, and failure risk through AI-enabled design and screening.

Founded

2021

Industry

Biotechnology

Tech Stack

Generative AI (proprietary platforms)

High-throughput virtual screening

Funding Track Record

Seed- 2021-11

Dealroom lists a November 2021 seed entry that names Genesis Capital and Iaso Ventures.

Seed- 2021-09-30

Company profile lists a last funding date of 2021-09-30 and indicates multiple funding rounds (Crunchbase records two rounds).

Investor Signal

“Investors named in public profiles include Genesis Capital and Iaso Ventures”

Founders

What we do

Related Companies

Company	HQ	Industry	Total Funding
GATC Health	🇺🇸Irvine, US	BiotechnologyDeepTech	$31M
NeuroDiscovery AI	🇺🇸Alpharetta, US	BiotechnologyDeepTechHealth	-
iollo	🇺🇸US	HealthSports	-
Prima Mente	🇬🇧London, GB	BiotechnologyDeepTech	-
Life Code Limited	🌍Hong Kong	BiotechnologyDeepTech	-

Join the Team

Open Rank Computational Scientist

HybridSan Francisco, CA, US

Hybrid • San Francisco, CA, US

Open Rank Computational Scientist, Drug Discovery

Responsibilities and Duties

Drive molecular tool design and advance display technologies
Spearhead innovation in discovery and delivery of new molecular modalities
Provide expertise within Molecular Biology and establish various expression strategies for any protein of interest

Teeming tracks opportunities at over 24,000 AI startups, then works with you to find (and land) the one you'll love.

Mobile Developer

ContractCambridge, GB

Contract • Cambridge, GB

Software Engineer

ContractMunich, DE

Contract • Munich, DE

Mobile Developer

Full-timeAmsterdam, NL

Full-time • Amsterdam, NL

AI Researcher

InternshipRotterdam, NL

Internship • Rotterdam, NL

Machine Learning Engineer

Part-timeAustin, US

Part-time • Austin, US

Product Designer

InternshipRotterdam, NL

Internship • Rotterdam, NL

Contribute to new target discovery with both technological expertise and scientific insights

Function as department representative in evaluating and establishing external collaborations

Build and maintain strong network with internal and external collaborators and stakeholders

Required Qualifications and Skills

M.Sc/Ph.D in Computer Science, Statistics, Cheminformatics, Bioinformatics, Computational Biology, Disease Biology or a related discipline
Strong computer science fundamentals
5+ years experience in complex algorithm development
Sound knowledge of statistics, data analytics, and data visualization
Strong coding skills in at least one high-level programming language (Python, R, Java, C++, etc)
Strong familiarity with Linux command-line environment

Preferred Qualifications

Experience in implementing and applying machine learning algorithms
Experience working with scalable algorithms utilizing large amounts of data
Understanding the fundamentals of biomolecular interactions
Molecular modeling experience in one or more of the following: virtual screening, pharmacophore modeling, QSAR, docking, structure or ligand-based modeling
Experience with cloud computing environments (AWS/Azure/GCE)
Experience with relational databases and/or NoSQL databases

· Green card holder or US citizen preferred. For highly qualified candidates, green card can be sponsored.

Compensation and Benefits

Excellent salary, commensurate with experience
Stock option, you will work as a co-owner in Ainnocence
Funding for professional development and conference attendance
Annual fitness stipend
Flexible work schedule and generous leaving rules
Great team with talented colleagues from different background

Please contact: hr@ainnocence.com

Ainnocence is a venture-backed next-generation biotech firm aiming to create a modularized self-evolving intelligent platform that integrates various advanced computational and wet lab technologies to revolutionize the drug discovery and development process. The founding team is a group of engineers and scientists with interdisciplinary education and industry backgrounds such as artificial intelligence, medicinal chemistry, structural biology, biomedical engineering, and pharmaceutical science.

Ainnocence is an Equal Opportunity Employer. We respect and seek to empower each individual and support the diverse cultures, perspectives, skills and experiences within our workforce.